4 research outputs found

    Acquired cardiac hypertrophy with outflow tract obstruction in a patient with severe Takayasu arteritis

    No full text
    Takayasu arteritis with coronary artery involvement is rare and its association with secondary cardiac hypertrophy with severe outflow tract obstruction is not common. We describe a case of Takayasu arteritis, diagnosed 10 years ago, whose coronary artery involvement and obstructive cardiac hypertrophy are ascertained after our investigations

    Artyku艂 oryginalnyZwi膮zek pomi臋dzy oty艂o艣ci膮 a dro偶no艣ci膮 t臋tniczych pomost贸w wie艅cowych w obserwacji odleg艂ej

    No full text
    Background: Arterial conduits having long-term patency rates have been increasingly used for bypass of coronary arteries although some risk factors for their occlusion such as recipient vessel size, older age, and hyperlipidaemia have been described. Obesity, on the other hand, has been well established as a coronary risk factor. However, the effects of obesity on patency of arterial conduits, especially the internal mammary artery, have not been studied previously. Aim: To assess the long-term effects of obesity on left internal mammary artery (LIMA) patency. Methods: Angiograms of all patients with a LIMA conduit only were analysed. Two groups were formed according to the LIMA patency: group 1 &#8211; patients with occluded LIMA (n = 59), and group 2 &#8211; patients with patent LIMA (n = 68). Baseline demographic, haemodynamic, and laboratory characteristics of patients in both groups were compared. Obesity was defined as body mass index 艂 30 kg/m2. Results: The mean BMI value in group 1 was significantly higher than in group 2 (30.4 &plusmn; 3.1 vs. 28.7 &plusmn; 4.7, p = 0.025). The two groups differed in time from surgery, drug use, and HDL cholesterol level. In addition, patients in both groups were categorised by BMI, and obese and non-obese groups were formed. Higher BMI was significantly associated with LIMA occlusion such that 71% of patients in group 1 had increased BMI, compared with 25% of patients in group 2 (p < 0.001). Multivariate analysis showed that multiple adjusted OR of the risk of LIMA occlusion was 7.41 (95% CI 3.38-16.28) for patients with increased BMI. Conclusions: : Obesity (艂 30 kg/m2) has a significant and independent negative effect on the patency of the LIMA graft.Wst臋p: Z uwagi na wysoki odsetek zachowanej po wielu latach dro偶no艣ci pomosty t臋tnicze s膮 preferowanym sposobem wykonywania operacji rewaskularyzacyjnych (CABG). Istniej膮 pewne czynniki zwi臋kszaj膮ce ryzyko zamkni臋cia, do kt贸rych nale偶膮 przekr贸j naczynia chorego, wiek oraz hiperlipidemia. Z kolei oty艂o艣膰 jest dobrze udokumentowanym czynnikiem ryzyka choroby wie艅cowej. Dotychczas zwi膮zek pomi臋dzy oty艂o艣ci膮 a dro偶no艣ci膮 pomost贸w t臋tniczych, szczeg贸lnie z wykorzystaniem t臋tnicy piersiowej wewn臋trznej (LIMA), nie by艂 badany. Cel: Ocena zwi膮zku pomi臋dzy oty艂o艣ci膮 a dro偶no艣ci膮 pomost贸w t臋tniczych w obserwacji d艂ugoterminowej. Metody: Poddano analizie angiogramy wszystkich chorych z LIMA. Bior膮c pod uwag臋 dro偶no艣膰 LIMA, utworzono dwie grupy chorych: grupa 1 &#8211; chorzy z zamkni臋tym pomostem (n = 59), oraz grupa 2 &#8211; chorzy z dro偶n膮 LIMA (n = 68). Por贸wnano dane demograficzne, hemodynamiczne i laboratoryjne obu grup. Oty艂o艣膰 zdefiniowano jako indeks masy cia艂a (BMI) 艂 30 kg/m2. Wyniki: 艢rednia warto艣膰 BMI w grupie 1 by艂a istotnie wy偶sza ni偶 w grupie 2 (30,4 &plusmn; 3,1 vs 28,7 &plusmn; 4,7, p = 0,025). Obie grupy r贸偶ni艂y si臋 r贸wnie偶 pod wzgl臋dem czasu, kt贸ry up艂yn膮艂 od zabiegu chirurgicznego, stosowanych lek贸w i st臋偶enia HDL-cholesterolu. Dodatkowo chorych podzielono na oty艂ych i nieoty艂ych. Oty艂o艣膰 wi膮za艂a si臋 ze zwi臋kszonym ryzykiem zamkni臋cia LIMA: stwierdzono j膮 u 71% chorych z grupy 1 wobec 25% z grupy 2 (p < 0,001). Analiza wieloczynnikowa wykaza艂a, 偶e ryzyko zamkni臋cia LIMA by艂o 7,41 razy wy偶sze u chorych oty艂ych (95% CI 3,38&#8211;16,28). Wnioski: Oty艂o艣膰 jest istotnym i niezale偶nym czynnikiem ryzyka zamkni臋cia pomostu t臋tniczego w obserwacji odleg艂ej

    Metabolic syndrome increases the risk of significant coronary artery involvement in patients with peripheral artery disease

    No full text
    Background Peripheral artery disease is a common condition, mainly associated with clinical cardiovascular risk factors. Patients with peripheral artery disease suffer from coronary artery disease-related complications. On the other hand, metabolic syndrome, as a constellation of specific risk factors, represents a risk factor for cardiovascular mortality. Metabolic syndrome might increase the risk of significant coronary artery disease in patients with peripheral artery disease. We aimed to examine the association of metabolic syndrome with the angiographically shown coronary artery involvement in patients with peripheral artery disease

    Fine vs. coarse atrial fibrillation: Which one is more risky?

    No full text
    Background: Atrial fibrillation (AF) is a frequent arrhythmia, associated with morbidity and mortality. It is identified by two types on surface electrocardiogram as fine and coarse AF. We aimed to search the association of subtypes of AF with clinical parameters. Methods: Eight hundred and eleven consecutive patients, who had AF attack which lasted longer than 24 h or more, were evaluated along with clinical and laboratory data. Results: Coarse AF was noticed in 51.7% (n = 419), and fine AF in 48.3% (n = 392). Sex was associated with subtype of AF such that coarse AF was present in 46.5% of male patients, but in 56.1% of female patients (p = 0.009). Coarse AF was present in 85.3% of patients with mitral stenosis, whereas it was present in 35.3% of patients with normal heart valve (p < 0.001).). Patients having fine AF were significantly older than those having coarse AF (64 +/- 12, 57 +/- 13 years, p < 0.001). 19.6% of those with coarse AF had history of cerebrovascular event (CVE), whereas 13.5% of those with fine AF had history of CVE (p = 0.021). After controlling for age in the multivariable logistic regression analysis, presence of coarse AF (B = 1.585, p = 0.031) was found to be independently associated with the history of CVE. Conclusion: AF is identified by two morphological forms on the surface electrocardiogram. These two forms were found to be associated with different clinical parameters, acting on vascular endpoints differently. Copyright (c) 2007 S. Karger AG, Basel
    corecore